Breaking News
BREAKING: DOJ Signs Cannabis into Schedule III
WASHINGTON – Today, the federal government took its most consequential ...
Portugal Medical Cannabis Outpaces 2025 Export Run Rate
LISBON – Portugal's medicines regulator, Infarmed, has confirmed that the ...
UMiami Hands Over Its 1994 Ibogaine Research to Washington
LOS ANGELES – The University of Miami has donated its ...
UN Approves WHO Recommendation On Rescheduling Medical Cannabis
In a move that could have a massive impact on marijuana reform efforts worldwide, the United Nations Commission on Narcotic Drugs (CND) has accepted a recommendation put forth by the World Health Organization (WHO) to ...
Johnson & Johnson Signs On to Lead Delix’s $85M Series C
NEW BRUNSWICK – Johnson & Johnson has agreed to lead a Series C financing for Delix Therapeutics, the biotech developing non-hallucinogenic drugs designed to promote neuroplasticity in patients with serious psychiatric conditions. The round is ...
Analysis: Wall Street Quietly Tests the Water In Cannabis
NEW YORK- For years, institutional investors have largely remained outside the publicly traded Cannabis market. Federal illegality, regulatory uncertainty, limited access to major exchanges and disappointing stock performance have kept most major investment firms on ...
Earnings Season: Cannabis Operators Deliver a Different Kind of Q2 2026
LOS ANGELES – The Cannabis industry wraps up its second-quarter earnings, and the aggregate picture carries a theme that would have been harder to locate a few years ago. Operators are making money. Profitability, not ...
